The Food and Drug Administration has started to move generic drug applications to the front of the line if they compete with high-priced products.

Sens. Susan Collins, R-Maine, and Claire McCaskill, D-Mo., filed legislation in March calling for the agency to change the way it prioritizes generic drug applications. The agency has since told the senators, who lead the Senate Special Committee on Aging, that they are able to do it without legislation.